BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ong CAJ, Lao-Sirieix P, Fitzgerald RC. Biomarkers in Barrett’s esophagus and esophageal adenocarcinoma: Predictors of progression and prognosis. World J Gastroenterol 2010; 16(45): 5669-5681 [PMID: 21128316 DOI: 10.3748/wjg.v16.i45.5669]
URL: https://www.wjgnet.com/1007-9327/full/v16/i45/5669.htm
Number Citing Articles
1
Romana Illig, Eckhard Klieser, Tobias Kiesslich, Daniel Neureiter. GERD—Barrett—Adenocarcinoma: Do We Have Suitable Prognostic and Predictive Molecular Markers?Gastroenterology Research and Practice 2013; 2013: 1 doi: 10.1155/2013/643084
2
Xiaojuan Pang, Yuxin Shu, Zhiyuan Niu, Wei Zheng, Haochen Wu, Yan Lu, Pingping Shen. PPARγ1 phosphorylation enhances proliferation and drug resistance in human fibrosarcoma cellsExperimental Cell Research 2014; 322(1): 30 doi: 10.1016/j.yexcr.2014.01.010
3
Adam Frankel, Nicola Armour, Derek Nancarrow, Lutz Krause, Nicholas Hayward, Guy Lampe, B. Mark Smithers, Andrew Barbour. Genome-wide analysis of esophageal adenocarcinoma yields specific copy number aberrations that correlate with prognosisGenes, Chromosomes and Cancer 2014; 53(4): 324 doi: 10.1002/gcc.22143
4
Ali H. Zaidi, Vanathi Gopalakrishnan, Pashtoon M. Kasi, Xuemei Zeng, Usha Malhotra, Jeya Balasubramanian, Shyam Visweswaran, Mai Sun, Melanie S. Flint, Jon M. Davison, Brian L. Hood, Thomas P. Conrads, Jacques J. Bergman, William L. Bigbee, Blair A. Jobe. Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinomaCancer 2014; 120(24): 3902 doi: 10.1002/cncr.28963
5
Hao Chen, Yu Fang, Whitney Tevebaugh, Roy C. Orlando, Nicholas J. Shaheen, Xiaoxin Chen. Molecular Mechanisms of Barrett’s EsophagusDigestive Diseases and Sciences 2011; 56(12): 3405 doi: 10.1007/s10620-011-1885-6
6
C M den Hoed, M van Blankenstein, J Dees, E J Kuipers. The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinomaBritish Journal of Cancer 2011; 105(2): 200 doi: 10.1038/bjc.2011.214
7
Richard G.H. Cotton, Rupert Langer, Trevor Leong, Jan Martinek, Vikash Sewram, Mark Smithers, Paul E. Swanson, You-Lin Qiao, Harushi Udagawa, Masaki Ueno, Meng Wang, Wen-Qiang Wei, Russell E. White. Coping with esophageal cancer approaches worldwideAnnals of the New York Academy of Sciences 2014; 1325(1): 138 doi: 10.1111/nyas.12522
8
Nai-Jun Fan, Chun-Fang Gao, Chang-Song Wang, Guang Zhao, Jing-Jing Lv, Xiu-Li Wang, Guang-Hui Chu, Jian Yin, Dong-Hui Li, Xiao Chen, Xu-Tao Yuan, Nian-Long Meng. Identification of the up-regulation of TP-alpha, collagen alpha-1(VI) chain, and S100A9 in esophageal squamous cell carcinoma by a proteomic methodJournal of Proteomics 2012; 75(13): 3977 doi: 10.1016/j.jprot.2012.05.008
9
Vani Konda, Irving Waxman. Response to Ganz and YappAmerican Journal of Gastroenterology 2012; 107(11): 1757 doi: 10.1038/ajg.2012.310
10
VINCENZA CONTEDUCA, DOMENICO SANSONNO, GIUSEPPE INGRAVALLO, STEFANIA MARANGI, SABINO RUSSI, GIANFRANCO LAULETTA, FRANCO DAMMACCO. Barrett’s esophagus and esophageal cancer: An overviewInternational Journal of Oncology 2012; 41(2): 414 doi: 10.3892/ijo.2012.1481
11
Tony E. Godfrey, Santhoshi Bandla, Virginia R. Litle, Jeffrey H. Peters. Shackelford's Surgery of the Alimentary Tract2013; : 382 doi: 10.1016/B978-1-4377-2206-2.00032-4
12
Chin-Ann J. Ong, Joel Shapiro, Katie S. Nason, Jon M. Davison, Xinxue Liu, Caryn Ross-Innes, Maria O'Donovan, Winand N.M. Dinjens, Katharina Biermann, Nicholas Shannon, Susannah Worster, Laura K.E. Schulz, James D. Luketich, Bas P.L. Wijnhoven, Richard H. Hardwick, Rebecca C. Fitzgerald. Three-Gene Immunohistochemical Panel Adds to Clinical Staging Algorithms to Predict Prognosis for Patients With Esophageal AdenocarcinomaJournal of Clinical Oncology 2013; 31(12): 1576 doi: 10.1200/JCO.2012.45.9636
13
Gemma Maddalo, Matteo Fassan, Romilda Cardin, Marika Piciocchi, Filippo Marafatto, Massimo Rugge, Giovanni Zaninotto, Caterina Pozzan, Carlo Castoro, Alberto Ruol, Alessandra Biasiolo, Fabio Farinati. Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal CancerJournal of Clinical Gastroenterology 2018; 52(5): 401 doi: 10.1097/MCG.0000000000000790
14
Lei Zhu, Lin Dong, Minghao Feng, Fugui Yang, Wenhao Jiang, Zhiyuan Huang, Fabing Liu, Lingwei Wang, Guangxue Wang, Qinchuan Li. Profiles of autophagy-related genes in esophageal adenocarcinomaBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07416-w
15
Chidi Amadi, Piers Gatenby. Barrett’s oesophagus: Current controversiesWorld Journal of Gastroenterology 2017; 23(28): 5051-5067 doi: 10.3748/wjg.v23.i28.5051
16
Florine Kastelein, Katharina Biermann, Ewout W Steyerberg, Joanne Verheij, Marit Kalisvaart, Leendert H J Looijenga, Hans A Stoop, Laurens Walter, Ernst J Kuipers, Manon C W Spaander, Marco J Bruno. Value of α-methylacyl-CoA racemase immunochemistry for predicting neoplastic progression in Barrett's oesophagusHistopathology 2013; : n/a doi: 10.1111/his.12216
17
Richard H. Lash, Thomas M. Deas, Frank H. Wians. Healthcare Cost of Over-Diagnosis of Low-Grade Dysplasia in Barrett’s EsophagusAdvances in Therapy 2016; 33(4): 684 doi: 10.1007/s12325-016-0308-7
18
Tatiana Benaglia, Linda D. Sharples, Rebecca C. Fitzgerald, Georgios Lyratzopoulos. Health Benefits and Cost Effectiveness of Endoscopic and Nonendoscopic Cytosponge Screening for Barrett's EsophagusGastroenterology 2013; 144(1): 62 doi: 10.1053/j.gastro.2012.09.060
19
C-I Geppert, P Rümmele, M Sarbia, R Langer, M Feith, L Morrison, E Pestova, R Schneider-Stock, A Hartmann, T T Rau. Multi-colour FISH in oesophageal adenocarcinoma—predictors of prognosis independent of stage and gradeBritish Journal of Cancer 2014; 110(12): 2985 doi: 10.1038/bjc.2014.238
20
Oliver M. Fisher, Reginald V.N. Lord. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set2019; : 323 doi: 10.1016/B978-0-323-40232-3.00032-7
21
Wei Chen, Kuan-Kei Kong, Xin-Ke Xu, Cheng Chen, Hui Li, Fang-Yu Wang, Xiao-Fang Peng, Zhan Zhang, Ping Li, Jun-Liang Li, Fang-Cheng Li. Downregulation of miR‑205 is associated with glioblastoma cell migration, invasion, and the epithelial-mesenchymal transition, by targeting ZEB1 via the Akt/mTOR signaling pathwayInternational Journal of Oncology 2017;  doi: 10.3892/ijo.2017.4217
22
Helen G. Coleman, Shivaram Bhat, Brian T. Johnston, Damian McManus, Anna T. Gavin, Liam J. Murray. Tobacco Smoking Increases the Risk of High-Grade Dysplasia and Cancer Among Patients With Barrett's EsophagusGastroenterology 2012; 142(2): 233 doi: 10.1053/j.gastro.2011.10.034
23
Nabil P. Rizk, Elliot L. Servais, Laura H. Tang, Camelia S. Sima, Hans Gerdes, Martin Fleisher, Valerie W. Rusch, Prasad S. Adusumilli. Tissue and Serum Mesothelin Are Potential Markers of Neoplastic Progression in Barrett's Associated Esophageal AdenocarcinomaCancer Epidemiology Biomarkers & Prevention 2012; 21(3): 482 doi: 10.1158/1055-9965.EPI-11-0993
24
Jiongyuan Xu, Lizhi Niu, Feng Mu, Shupeng Liu, Yin Leng, Mengtian Liao, Jianying Zeng, Fei Yao, Jibing Chen, Jialiang Li, Kecheng Xu. Percutaneous comprehensive cryoablation for metastatic esophageal cancer after failure of radical surgeryCryobiology 2013; 67(3): 363 doi: 10.1016/j.cryobiol.2013.10.004
25
Joana Cardoso, Marta Mesquita, António Dias Pereira, Mónica Bettencourt-Dias, Paula Chaves, José B. Pereira-Leal, John P. Lynch. CYR61 and TAZ Upregulation and Focal Epithelial to Mesenchymal Transition May Be Early Predictors of Barrett’s Esophagus Malignant ProgressionPLOS ONE 2016; 11(9): e0161967 doi: 10.1371/journal.pone.0161967
26
Alfred King-yin Lam. Esophageal Cancer2015; : 25 doi: 10.1007/978-3-319-20068-2_2
27
Adam Frankel, Derek Nancarrow, Nicola Wayte, Andrew Barbour. Clinical issues in oesophageal adenocarcinoma: could DNA copy number hold the key?ANZ Journal of Surgery 2012; 82(9): 599 doi: 10.1111/j.1445-2197.2012.06144.x
28
Xiao-Fu Li, Zheng Jiang, Ying Gao, Chun-Xiang Li, Bao-Zhong Shen. Combination of three-gene immunohistochemical panel and magnetic resonance imaging-detected extramural vascular invasion to assess prognosis in non-advanced rectal cancer patientsWorld Journal of Gastroenterology 2016; 22(38): 8576-8583 doi: 10.3748/wjg.v22.i38.8576
29
Ishaan Maitra, Ravindra Sudhachandra Date, Francis Luke Martin. Towards screening Barrett’s oesophagus: current guidelines, imaging modalities and future developmentsClinical Journal of Gastroenterology 2020; 13(5): 635 doi: 10.1007/s12328-020-01135-2
30
Danielle M. Battle, Sanjika Dias Gunasekara, Graeme R. Watson, Eltayeb Mohamed Ahmed, Colin G. Saysell, Naveed Altaf, Abayomi L. Sanusi, Phanibhushana C. Munipalle, David Scoones, Julie Walker, Yks Viswanath, Adam M. Benham. Expression of the Endoplasmic Reticulum Oxidoreductase Ero1α in Gastro-Intestinal Cancer Reveals a Link Between Homocysteine and Oxidative Protein FoldingAntioxidants & Redox Signaling 2013; 19(1): 24 doi: 10.1089/ars.2012.4651
31
A.G. Neto, R.A. Hickman, A. Khan, C. Nossa, Z. Pei. The Microbiota in Gastrointestinal Pathophysiology2017; : 1 doi: 10.1016/B978-0-12-804024-9.00001-X
32
Santhoshi Bandla, Jeffrey H. Peters, David Ruff, Shiaw-Min Chen, Chieh-Yuan Li, Kunchang Song, Kimberly Thoms, Virginia R. Litle, Thomas Watson, Nikita Chapurin, Michal Lada, Arjun Pennathur, James D. Luketich, Derick Peterson, Austin Dulak, Lin Lin, Adam Bass, David G. Beer, Tony E. Godfrey, Zhongren Zhou. Comparison of Cancer-Associated Genetic Abnormalities in Columnar-Lined Esophagus Tissues With and Without Goblet CellsAnnals of Surgery 2014; 260(1): 72 doi: 10.1097/SLA.0000000000000424
33
L H McCormick Matthews, F Noble, J Tod, E Jaynes, S Harris, J N Primrose, C Ottensmeier, G J Thomas, T J Underwood. Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinomaBritish Journal of Cancer 2015; 113(1): 107 doi: 10.1038/bjc.2015.179
34
Roger Yazbeck, Simone E Jaenisch, David I Watson. From blood to breath: New horizons for esophageal cancer biomarkersWorld Journal of Gastroenterology 2016; 22(46): 10077-10083 doi: 10.3748/wjg.v22.i46.10077
35
H. Ece Arslan Ozcan, Turgut Anuk, Ozkan Ozden. Expression profile and cellular localizations of mucin proteins, CK7, and cytoplasmic p27 in Barrett’s esophagus and esophageal adenocarcinomaAdvances in Medical Sciences 2018; 63(2): 296 doi: 10.1016/j.advms.2018.04.002
36
Miklós Máté, Béla Molnár. A Relation Between Cell Cycle and Intestinal Metaplasia in Oesophageal Biopsies Using Optical and Digital MicroscopyPathology & Oncology Research 2015; 21(3): 669 doi: 10.1007/s12253-014-9873-8
37
Alfred K. Lam. Esophageal Cancer2020; : 33 doi: 10.1007/978-3-030-29832-6_2
38
Zeeshan Ramzan, Ammar B Nassri, Sergio Huerta. The use of imaging and biomarkers in diagnosing Barrett’s esophagus and predicting the risk of neoplastic progressionExpert Review of Molecular Diagnostics 2014; 14(5): 575 doi: 10.1586/14737159.2014.919856
39
Anna Mokrowiecka, Lothar Veits, Christina Falkeis, Jacek Musial, Radzislaw Kordek, Mariusz Lochowski, Jozef Kozak, Agnieszka Wierzchniewska-Lawska, Michael Vieth, Ewa Malecka-Panas. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa—Barrett’s esophagus—early esophageal adenocarcinoma—advanced esophageal adenocarcinoma sequencePathology - Research and Practice 2017; 213(3): 205 doi: 10.1016/j.prp.2016.12.018
40
Irina Kalatskaya. Overview of major molecular alterations during progression from Barrett's esophagus to esophageal adenocarcinomaAnnals of the New York Academy of Sciences 2016; 1381(1): 74 doi: 10.1111/nyas.13134
41
Marilanda Ferreira Bellini, Aline Cristina Targa Cadamuro, Maysa Succi, Marcela Alcântara Proença, Ana Elizabete Silva. Alterations of theTP53Gene in Gastric and Esophageal CarcinogenesisJournal of Biomedicine and Biotechnology 2012; 2012: 1 doi: 10.1155/2012/891961
42
D. V. Danilov, A. G. Shuleshova, K. A. Bondareva. The current state of the art in the treatment of erosive esophagitisDokazatel'naya gastroenterologiya 2017; 6(1): 26 doi: 10.17116/dokgastro20176126-30
43
Chaohui Wu, Minjie Li, Chao Hu, Hongbing Duan. Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinomaMolecular Biology Reports 2014; 41(3): 1257 doi: 10.1007/s11033-013-2970-z
44
Hugo Ford, Ioannis Gounaris. Docetaxel and its potential in the treatment of refractory esophagogastric adenocarcinomaTherapeutic Advances in Gastroenterology 2015; 8(4): 189 doi: 10.1177/1756283X15585468
45
Anne-Marie Byrne, Spiros Bekiaris, Gina Duggan, David Prichard, Murat Kirca, Stephen Finn, John V Reynolds, Dermot Kelleher, Aideen Long. Golgi phosphoprotein 2 (GOLPH2) is a novel bile acid-responsive modulator of oesophageal cell migration and invasionBritish Journal of Cancer 2015; 113(9): 1332 doi: 10.1038/bjc.2015.350